Edition:
United States

Capricor Therapeutics Inc (CAPR.OQ)

CAPR.OQ on NASDAQ Stock Exchange Capital Market

1.81USD
23 Feb 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.81
Open
$1.82
Day's High
$1.86
Day's Low
$1.74
Volume
34,683
Avg. Vol
125,384
52-wk High
$4.25
52-wk Low
$0.63

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.31 -0.117
Jun '17 1.00 -0.157
Mar '17 0.88 -0.171
FY 2016 Dec '16 0.91 -0.211
Sep '16 0.75 -0.292
Jun '16 1.13 -0.261
Mar '16 1.22 -0.258
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 2.90 2.90 2.90 0.00
Earnings (per share)
Year Ending Dec-18 1 -0.54 -0.54 -0.54 -1.00
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 195.87 33.62
P/E High - Last 5 Yrs. -- 285.81 46.17
P/E Low - Last 5 Yrs. -- 93.64 24.19
Beta -3.57 0.81 0.81
Price to Sales (TTM) 15.02 137.83 8.35
Price to Book (MRQ) -- 20.52 5.22
Price to Tangible Book (MRQ) -- 28.04 6.44
Price to Cash Flow (TTM) -- 128.31 25.88
% Owned Institutions 9.46 11.86 2.30

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.85 5.23
Payout Ratio(TTM) -- 8.14 41.36

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -58.05 64.95 9.76
Sales (TTM) vs TTM 1 Yr. Ago -26.51 58.16 7.57
Sales - 5 Yr. Growth Rate 24.17 33.63 10.22
EPS (MRQ) vs Qtr. 1 Yr. Ago 59.89 -94.99 16.24
EPS (TTM) vs TTM 1 Yr. Ago 35.46 -- --
EPS - 5 Yr. Growth Rate -- 46.89 11.55
Capital Spending - 5 Yr. Growth Rate 149.85 43.77 14.75

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.42
Current Ratio (MRQ) 0.91 6.12 3.39
LT Debt to Equity (MRQ) -- 16.21 12.39
Total Debt to Equity (MRQ) -- 18.27 15.84
Interest Coverage (TTM) -60.53 -156.52 38.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 46.30 54.79
Gross Margin - 5 Yr. Avg. -- 55.30 52.59
EBITD Margin (TTM) -398.74 -- --
EBITD - 5 Yr. Avg -265.04 -230.69 14.70
Operating Margin (TTM) -451.83 -487.70 4.10
Operating Margin - 5 Yr. Avg. -287.51 -247.29 9.99
Pre-Tax Margin (TTM) -464.63 -463.92 4.83
Pre-Tax Margin - 5 Yr. Avg. -292.39 -253.91 10.24
Net Profit Margin (TTM) -464.63 -445.10 1.55
Net Profit Margin - 5 Yr. Avg. -292.39 -257.36 6.54
Effective Tax Rate (TTM) -- 0.46 21.93
Effective Tax Rate - 5 Yr. Avg. -- 17.72 24.14

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,863,557 817,554,851
Net Income/Employee (TTM) -- -520,338 95,586,843
Receivable Turnover (TTM) 3.64 13.83 5.44
Inventory Turnover (TTM) -- 2.38 3.52
Asset Turnover (TTM) 0.15 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -71.49 -1.04 10.73
Return on Assets - 5 Yr. Avg. -96.30 -0.14 12.03
Return on Investment (TTM) -170.25 -0.71 13.63
Return on Investment - 5 Yr. Avg. -149.85 2.18 15.76
Return on Equity (TTM) -- -3.37 15.39
Return on Equity - 5 Yr. Avg. -- -1.91 17.03
  1 Year 3 Year 5 Year
Sales % -27.53 99.55 24.17
EPS (TTM) % -25.39 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Capricor Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -13.40 -9.44 49 77
13 Week -13.81 -18.35 47 94
26 Week 70.75 51.84 99 91
52 Week -38.44 -47.03 46 89
YTD 14.56 11.48 99 92
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 9.46%
# of Holders: 25
Total Shares Held: 2,431,029
3 Mo. Net Change: 1,437,262
# New Positions: 7
# Closed Positions: 4
# Increased Positions: 13
# Reduced Positions: 5
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.